Kymera Therapeutics, Inc.
NASDAQ:KYMR
35.1 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| -223.858 | -146.962 | -154.808 | -100.217 | -45.593 | -41.246 | -21.467 |
| Depreciation & Amortization
| 7.373 | 3.565 | 2.977 | 2.397 | 1.763 | 0.825 | 0.205 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 1.571 | 0 | 0 |
| Stock Based Compensation
| 55.012 | 43.118 | 35.48 | 24.972 | 5.19 | 1.196 | 0.648 |
| Change In Working Capital
| -23.97 | 2.682 | -37.623 | -61.923 | 124.867 | 56.687 | 2.308 |
| Accounts Receivables
| 15 | -15 | -2.401 | 0.577 | -0.577 | 0.148 | -0.148 |
| Inventory
| 0 | 23.372 | 2.401 | 8.708 | 6.879 | -0.148 | 0 |
| Accounts Payables
| -0.307 | 2.038 | 0.253 | 0.054 | 0.99 | 0.904 | 0.824 |
| Other Working Capital
| -38.663 | -7.728 | -37.876 | -71.262 | 117.575 | 55.783 | 1.484 |
| Other Non Cash Items
| -9.058 | -5.229 | 0.889 | 5.825 | 0.332 | 0.443 | 0.443 |
| Operating Cash Flow
| -194.501 | -102.826 | -153.085 | -128.946 | 88.13 | 17.905 | -17.863 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| -12.838 | -34.48 | -2.836 | -1.597 | -9.096 | -0.532 | -1.356 |
| Acquisitions Net
| 0 | 0 | -20.519 | 5.807 | 413.492 | 0 | 0 |
| Purchases Of Investments
| -901.226 | -189.151 | -445.972 | -456.404 | -529.382 | -15.954 | 0 |
| Sales Maturities Of Investments
| 496.004 | 363.517 | 469.327 | 358.166 | 115.89 | 0 | 0 |
| Other Investing Activites
| 13.983 | 0 | 20.519 | -5.807 | -413.492 | -15.954 | 0 |
| Investing Cash Flow
| -404.077 | 139.886 | 20.519 | -99.835 | -422.588 | -16.486 | -1.356 |
| Financing Activities: | |||||||
| Debt Repayment
| -1.576 | -0.076 | -1.13 | -0.849 | -0.554 | -0.371 | -0.295 |
| Common Stock Issued
| 596.619 | 4.268 | 149.825 | 243.106 | 196.673 | 35.282 | 53.227 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 13.808 | 4.268 | 4.304 | 8.023 | 93.143 | 35.282 | 53.227 |
| Financing Cash Flow
| 608.851 | 4.192 | 152.999 | 250.28 | 289.262 | 34.911 | 52.932 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 10.273 | 41.252 | 20.433 | 21.499 | -45.196 | 36.33 | 33.713 |
| Cash At End Of Period
| 126.05 | 115.777 | 74.525 | 54.092 | 32.593 | 77.789 | 41.459 |